Neuberger Berman Group LLC trimmed its stake in Equifax, Inc. (NYSE:EFX - Free Report) by 19.4% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 478,861 shares of the credit services provider's stock after selling 115,530 shares during the quarter. Neuberger Berman Group LLC owned 0.39% of Equifax worth $116,631,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in EFX. Caitong International Asset Management Co. Ltd acquired a new position in Equifax in the 1st quarter worth about $83,000. S Bank Fund Management Ltd bought a new stake in shares of Equifax in the 1st quarter valued at approximately $370,000. National Pension Service increased its holdings in Equifax by 16.6% in the first quarter. National Pension Service now owns 177,435 shares of the credit services provider's stock worth $43,216,000 after buying an additional 25,297 shares during the last quarter. LGT Group Foundation raised its position in Equifax by 85.9% during the first quarter. LGT Group Foundation now owns 143,046 shares of the credit services provider's stock valued at $34,840,000 after acquiring an additional 66,118 shares in the last quarter. Finally, LGT Fund Management Co Ltd. raised its position in Equifax by 21.1% during the first quarter. LGT Fund Management Co Ltd. now owns 21,469 shares of the credit services provider's stock valued at $5,229,000 after acquiring an additional 3,740 shares in the last quarter. 96.20% of the stock is owned by hedge funds and other institutional investors.
Equifax Stock Performance
Shares of EFX stock traded down $0.33 during mid-day trading on Friday, reaching $247.74. The stock had a trading volume of 648,630 shares, compared to its average volume of 1,253,604. Equifax, Inc. has a one year low of $199.98 and a one year high of $309.63. The firm has a market cap of $30.67 billion, a PE ratio of 48.48, a P/E/G ratio of 2.99 and a beta of 1.64. The firm's 50 day simple moving average is $254.62 and its 200 day simple moving average is $251.03. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 0.79.
Equifax (NYSE:EFX - Get Free Report) last posted its quarterly earnings results on Tuesday, July 22nd. The credit services provider reported $2.00 earnings per share for the quarter, topping analysts' consensus estimates of $1.92 by $0.08. Equifax had a net margin of 10.95% and a return on equity of 18.89%. The firm had revenue of $1.54 billion for the quarter, compared to the consensus estimate of $1.51 billion. During the same quarter in the previous year, the company earned $1.82 earnings per share. The business's revenue was up 7.4% compared to the same quarter last year. On average, analysts forecast that Equifax, Inc. will post 7.58 EPS for the current year.
Analysts Set New Price Targets
Several analysts have commented on the stock. Robert W. Baird decreased their target price on shares of Equifax from $310.00 to $289.00 and set an "outperform" rating for the company in a research report on Wednesday, July 23rd. Oppenheimer lowered their target price on shares of Equifax from $296.00 to $279.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 23rd. Citigroup cut their target price on Equifax from $294.00 to $290.00 and set a "buy" rating on the stock in a report on Wednesday, July 23rd. Bank of America downgraded Equifax from a "buy" rating to a "neutral" rating and decreased their price target for the stock from $300.00 to $285.00 in a research note on Monday, June 23rd. Finally, JPMorgan Chase & Co. cut their price objective on Equifax from $277.00 to $272.00 and set an "overweight" rating on the stock in a research note on Wednesday, July 23rd. Seven research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $285.00.
Read Our Latest Stock Analysis on EFX
Insider Buying and Selling
In other Equifax news, CEO Mark W. Begor sold 48,264 shares of Equifax stock in a transaction that occurred on Monday, July 28th. The stock was sold at an average price of $241.71, for a total transaction of $11,665,891.44. Following the sale, the chief executive officer directly owned 142,872 shares of the company's stock, valued at approximately $34,533,591.12. The trade was a 25.25% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.40% of the stock is currently owned by corporate insiders.
Equifax Profile
(
Free Report)
Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.
Featured Articles

Before you consider Equifax, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Equifax wasn't on the list.
While Equifax currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.